Aminopyridinecarboxamide-based inhibitors: Structure–activity relationship

Aminopyridinecarboxamide-based iKK-2 inhibitors were synthesized and tested leading to the 2-amino-5-chloropyridine-4-carboxamides as potent inhibitors with improved cellular activity. Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry Vol. 18; no. 1; pp. 403 - 414
Main Authors: Bonafoux, Dominique F., Bonar, Sheri L., Clare, Michael, Donnelly, Ann M., Glaenzer, Jeanette L., Guzova, Julia A., Huang, He, Kishore, Nandidni N., Koszyk, Francis J., Lennon, Patrick J., Libby, Adam, Mathialagan, Sumathy, Oburn, David S., Rouw, Sharon A, Sommers, Cynthia D., Tripp, Catherine S., Vanella, Lori J., Weier, Richard, Wolfson, Serge G., Huang, Horng-Chih
Format: Journal Article
Language:English
Published: Amsterdam Elsevier Ltd 2010
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aminopyridinecarboxamide-based iKK-2 inhibitors were synthesized and tested leading to the 2-amino-5-chloropyridine-4-carboxamides as potent inhibitors with improved cellular activity. Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and in IL-1β stimulated synovial fibroblasts. The 2-amino-5-chloropyridine-4-carboxamides were identified as the most potent inhibitors with improved cellular activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2009.10.040